Trial Profile
A 52 week, multicentre, open label extension study of the safety, tolerability and efficacy of donepezil (Aricept) in Parkinson's disease patients with dementia
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Nov 2005
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Dementia; Parkinson's disease
- Focus Therapeutic Use
- 01 Nov 2005 New trial record.